Metastatic cellular fibrous histiocytoma  by Tseng, Yi-Teng et al.
lable at ScienceDirect
DERMATOLOGICA SINICA 34 (2016) 102e105Contents lists avaiDermatologica Sinica
journal homepage: http: / /www.derm-sinica.comCASE REPORTMetastatic cellular ﬁbrous histiocytoma
Yi-Teng Tseng, Kai-Lung Chen, Tsen-Fang Tsai*
Department of Dermatology, National Taiwan University Hospital, Taipei, Taiwana r t i c l e i n f o
Article history:
Received: Apr 7, 2015
Revised: Aug 7, 2015





TaiwanConﬂicts of interest: The authors declare that
non-ﬁnancial conﬂicts of interest related to the
discussed in this article.
* Corresponding author. Department of Dermatolog
Hospital, 7 Chung-Shan South Road, Taipei 100, Taiw
E-mail address: tftsai@yahoo.com (T.-F. Tsai).
http://dx.doi.org/10.1016/j.dsi.2015.09.001
1027-8117/Copyright © 2015, Taiwanese Dermatologic
creativecommons.org/licenses/by-nc-nd/4.0/).a b s t r a c t
Fibrous histiocytoma is a common benign cutaneous tumor. Although most cases of ﬁbrous histiocytoma
pursue an indolent course, rare cases have been reported that show aggressive courses with metastases
and fatality despite a benign pathology. Here, we present a 30-year-old man with metastatic cellular
ﬁbrous histiocytoma. To our knowledge, this is the ﬁrst case report of such a disease entity in Taiwan.
Copyright © 2015, Taiwanese Dermatological Association.
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creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Fibrous histiocytoma is a common cutaneous tumor characterized
pathologically by nonencapsulated proliferation of bland, spindle,
and histiocytoid cells in a fascicular and storiform growth pattern
with entrapment of collagen bundles. Although most cases of
ﬁbrous histiocytoma pursue an indolent course, rare cases have
been reported that show aggressive courses with metastases and
fatality despite a benignpathology.1,2 Here,wepresent a 30-year-old
man with metastatic cellular ﬁbrous histiocytoma. To our knowl-
edge, this is the ﬁrst case report of such a disease entity in Taiwan.
Case report
The 30-year-old male patient had no underlying diseases. He found
one 3 cm tumor on his right thigh at 27 years of age in January
2009. Total excision of the tumor was performed.Microscopically, it
showed a spindle cell tumor with storiform growth pattern and
focal myxoid degeneration with acanthosis of the overlying
epidermis (Figure 1A). The tumor cells had eosinophilic cytoplasm
and bland-looking nuclei (Figure 1B). Mitotic ﬁgures were scarce.
Occasional multinucleated giant cells were present. Immunohis-
tochemically, the tumor cells were immunoreactive to factor XIIIa
(Figure 1C), but not for CD34 and desmin.they have no ﬁnancial or
subject matter or materials
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al Association. Published by ElseviIn April 2009, multiple diffuse lung nodules were found inci-
dentally with a chest X-ray in a health examination. Computed
tomography of the chest also showed multiple lung nodules
(Figure 1D). Video-assisted throracoscopic wedge resection of part
of the right middle lung tissue was performed. Microscopically, the
tumor was composed of spindle-shaped histiocytes with frequent
storiform growth pattern. No mitosis, pleomorphism, or necrosis
was seen. The histologic ﬁnding was similar to his previous right
thigh tumor, and a metastatic ﬁbrous histiocytoma was favored.
The patient started to have chronic cough in November 2010.
Work-up for infectious diseases or other potential causes of chronic
cough yielded negative results. The patient was lost to follow-up
after December 2010.
In October 2014, he presented with progressive exertional dys-
pnea and one gradually enlarging mass on the right axilla noted for
>6 months (Figure 2A). Physical examination found multiple nod-
ules of various sizes on the trunk, with the largest one noted on the
right axilla. Microscopic examination of one of the lesions on the
left upper abdomen (Figure 2B) showed proliferation of cellular
ovoid ﬁbrohistiocytic cells with a storiform growth pattern
compatible with ﬁbrous histiocytoma (Figure 2C). Immunohis-
tochemically, the tumor cells were positive for factor XIIIa
(Figure 2D) and negative for creatine kinase, CD34, and c-kit. The
histological ﬁndings and immunohistochemistry showed similarity
to his previous right thigh tumor, and considering the clinical
course, metastases of the initial right thigh and ﬁbrous histiocy-
toma were favored.
Using computed tomography, an increase in the size and num-
ber of lung nodules was found compared with 2009 (Figure 3A).
Also, multiple metastatic lesions in muscles and subcutaneous
tissue (Figure 3B), pathological compression fracture at the L3er Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
Figure 1 (A) Excision of the right thigh primary tumor was conducted in 2009. Histological examination shows a dermal tumor with hyperplasia of overlying epidermis [he-
matoxylin and eosin stain (H&E) 10]; (B) the tumor cells are bland, spindle, and histiocytoid cells in fascicular and storiform growth pattern (H&E 40); (C) immunohisto-
chemistry is positive for factor XIIIa (IHC); and (D) chest computed tomography scan shows multiple lung nodules in 2009.
Figure 2 (A) Clinical picture of the right axillary tumor; (B) biopsy was performed on the left upper abdominal tumor in 2014; (C) the metastatic lesion shows spindle and his-
tiocytoid tumor cells in fascicular and storiform growth pattern. The inset ﬁgure shows scarce mitotic ﬁgures (hematoxylin and eosin stain 40); and (D) immunohistochemistry
shows positive staining for factor XIIIa.
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Figure 3 (A) Computed tomography scan shows increase in size and number of lung nodules compared with 2009; (B) an intramuscular metastatic lesion is visible (arrow); and (C)
computed tomography scan shows an osteolytic lesion in the L3-spine with compression fracture.
Y.-T. Tseng et al. / Dermatologica Sinica 34 (2016) 102e105104vertebra (Figure 3C), and one hepatic lesion of an uncertain nature
were found.
Under the impression of metastatic cellular ﬁbrous histiocy-
toma, he declined chemotherapy and received imatinib 400 mg/
d from November 12, 2014 to December 15, 2014 with no objective
clinical improvement. The patient was then lost to follow-up.
Discussion
Fibrous histiocytoma is typically regarded as a benign tumor with
little potential for local recurrence and aggressive behavior. Pa-
thology typically shows nonencapsulated proliferation of bland,
spindle, and histiocytoid cells in a fascicular and storiform growth
pattern with entrapment of collagen bundles. Focal mitotic ﬁgures
and multinucleated giant cells are occasionally found. Several var-
iants are present, including cellular, aneurysmal, atypical, pali-
sading, and epithelioid variant. Although rare, certain cases of
metastatic ﬁbrous histiocytoma have been well documented.1,2
Since the ﬁrst case report of metastatic ﬁbrous histiocytoma in
1990,3 there have been at least 35 similar cases reported.4 These
cases showed no distinguishable features from nonmetastatic le-
sions in pathology despite a malignant clinical behavior.1,2
The most frequent primary lesion site of metastatic ﬁbrous
histiocytoma is on the lower limbs, followed by the tunk.1 Micro-
scopically, the most frequent variants are cellular, aneurysmal, and
atypical variant.1 The local recurrence rate are 2%, 26%, and 64% for
usual ﬁbrous histiocytomas, cellular variants, and ﬁbrous histio-
cytomas with metastasis, respectively.1 The age of presentation
ranged from 2 years to 68 years,1,2 with no sex predilection, and
average primary tumor size of 3.2 cm.1 The most frequently met-
astatic sites are lung, lymph nodes, soft tissue, and liver.1,2
There is currently no identiﬁed single risk factor for the devel-
opment of metastasis in ﬁbrous histiocytoma. The relative large
size of the primary lesion and early or frequent local recurrence are
more common in metastatic ﬁbrous histiocytoma.1,2,4 The clinical
ﬁndings which were mentioned above should raise the suspicionfor the potential of metastases, and warrant a close clinical follow-
up, along with a more detailed survey such as chest plain ﬁlm.
Charli-Joseph et al4 compared ﬁve cases of metastatic ﬁbrous
histiocytoma with ﬁve cases of cellular ﬁbrous histiocytoma and
seven cases of atypical ﬁbrous histiocytoma using array-based
comparative genomic hybridization analysis. A higher frequency
of chromosomal aberrations in metastatic ﬁbrous histiocytomawas
found. In addition, more frequent gains of chromosome 7 and
chromosome 8q, and loss of chromosome Xq were found in met-
astatic ﬁbrous histiocytomas. They suggested conducting array-
based comparative genomic hybridization analysis for the ﬁbrous
histiocytoma once there was clinical suspicion for metastatic
potential.
In our case, we could not exclude the possibility of multiple
occurrences, and also the possibility of the initial right thigh tumor
being a metastatic lesion but found ﬁrst. Nevertheless, the right
thigh tumor, lung nodules, and the left upper abdominal tumor do
share the same pathological ﬁndings.
There is currently no consensus on the treatment of metastatic
ﬁbrous histiocytoma. Some reported successful treatment with
resection of the metastatic lesions.5 Others reported using
chemotherapy for multiple metastases,1,2 including ifosfamide-
adriamycin-based regimen,6 radiation therapy, and one case has
been treated with sorafenib with limited effects.1,2
Knowing the limited effect of conventional therapy in his case,
our patient insisted on receiving imatinib treatment after reading
reports of dermatoﬁbrosarcoma protuberans.7 The patient experi-
enced severe myalgia and no obvious clinical improvement despite
the slight softening of the axillary lesion. Radiologically, the lesions
remained unchanged in plain chest X-ray. To our knowledge, this is
the ﬁrst case report of metastatic ﬁbrous histiocytoma treated with
imatinib.
In conclusion, although in most cases ﬁbrous histiocytoma are
benign lesions, the possibility of metastasis should be kept in mind,
especially since there is currently no optimal treatment for unre-
sectable metastatic cases.
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